drugset / Trial / NCT06837077
Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
In order to improve the medication convenience and compliance of patients and facilitates in the long-term control of disease condition, it is planned to reduced the number of injections to one per administration. The study aims to compare the safety and pharmacokinetics data to assess feasibility of single-site and multiple-site injection for administration.
Timeline
- Start
- 2025-03-14
- Primary completion
- 2025-06
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recaticimab | Monoclonal antibody | — | Subcutaneous |